API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Mirtazapine: Antidepressant Mechanisms, Therapeutic Versatility, and Clinical Impact

Mirtazapine is an antidepressant that belongs to a group of medicines called tetracyclic antidepressants which is used to treat depression.

Apr 28,2025  API

Eptifibatide: Mechanisms, Efficacy, and Cost - Effectiveness in Cardiology

Eptifibatide is a glycoprotein IIb/IIIa class platelet inhibitor drug that reduces ischemic cardiac events in specific patient populations.

Apr 27,2025  API

2,4,5-Trichloropyrimidine: From Synthetic Routes to Multifunctional Applications

2,4,5-Trichloropyrimidine is utilized in synthesizing potent ALK-5 inhibitors for anti-tumor treatment and EGFR inhibitors.

Apr 27,2025  API

Octanohydroxamic Acid: Chemical Properties, Synthesis and Applications

Octanohydroxamic Acid (Caprylhydroxamic Acid) is an important multifunctional compound with a hydroxamic acid functional group.

Apr 25,2025  API

A new method for synthesizing 5-Bromo-1-pentene

5-Bromo-1-pentene is used in multiple syntheses, and a new method offers simplicity, high yield (over 80%) and purity (over 99%) for industrial production.

Apr 25,2025  API

Promestriene: Efficacy, Safety, and Comparisons in Treating Vaginal Atrophy and Genitourinary Syndrome

Promestriene is a 3-propyl and 17b-methyl ether of estradiol that has an efficient action on vaginal atrophy while it is minimally absorbed.

Apr 24,2025  API

9-Bromoanthracene: Synthesis, Impurity Analysis and Thermochemical Behavior Studies

9-Bromoanthracene acts as an intermediate in the preparation of 9-substituted derivative of the polycyclic aromatic hydrocarbon.

Apr 24,2025  API

Aloin: Therapeutic Potential, Stability Concerns, and Microbiota Modulation

Aloin, a bioactive Aloe vera compound, shows promise in treating cancer and neurodegenerative diseases via neuroprotection.

Apr 24,2025  API

Cinchonidine: Synthesis, Applications in Anti-malarial Research and Catalysis

Cinchonidine can be used for synthesis of anti-malarial glycoconjugates, exploration of pnicogen bonding in catalysis, and synthesis of (+)-cinchonidine.

Apr 23,2025  API

Sustainable Pathways for L-Lactide Production

L-Lactide, a cyclic ester and key intermediate for poly(lactic acid)synthesis, is costly due to its complex production involving issues like racemization.

Apr 23,2025  API
Prev12345678910...Next>  Go to Page